AML With HIV Infection in The Era of Precision Oncology – Do We See The Light At The End of The Tunnel?

Sharada Mailankody; Ananth Pai; Ram Bhat; Karthik Udupa

doi:10.1007/s12288-023-01715-5

AML With HIV Infection in The Era of Precision Oncology – Do We See The Light At The End of The Tunnel?

Sharada Mailankody^*
, Ananth Pai
, Ram Bhat
, Karthik Udupa

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	356-358
Number of pages	3
Journal	Indian Journal of Hematology and Blood Transfusion
Volume	40
Issue number	2
DOIs	https://doi.org/10.1007/s12288-023-01715-5
Publication status	Accepted/In press - 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Hematology

Access to Document

10.1007/s12288-023-01715-5

Cite this

@article{ad4b7aac45334bb1b58598e14708d36c,

title = "AML With HIV Infection in The Era of Precision Oncology – Do We See The Light At The End of The Tunnel?",

author = "Sharada Mailankody and Ananth Pai and Ram Bhat and Karthik Udupa",

year = "2023",

doi = "10.1007/s12288-023-01715-5",

language = "English",

volume = "40",

pages = "356--358",

journal = "Indian Journal of Hematology and Blood Transfusion",

issn = "0971-4502",